{
    "2018-08-15": [
        [
            {
                "time": "2018-01-02",
                "original_text": "FANG Stocks Take Heat As Distribution Hits Nasdaq; Netflix Slumps 3.5%",
                "features": {
                    "keywords": [
                        "FANG",
                        "Nasdaq",
                        "Netflix",
                        "Distribution",
                        "Slumps"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "entertainment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "A Rare Genetic Aversion to Sweets Could Be Key to Fighting Obesity",
                "features": {
                    "keywords": [
                        "Genetic",
                        "Aversion",
                        "Sweets",
                        "Obesity"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Buy Stocks That Are Down, Not Up, Here",
                "features": {
                    "keywords": [
                        "Buy",
                        "Stocks",
                        "Down",
                        "Up"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Hurdles Ahead of Alnylam and Its Revolutionary New Drug",
                "features": {
                    "keywords": [
                        "Hurdles",
                        "Alnylam",
                        "Revolutionary",
                        "Drug"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-16",
                "original_text": "Allergan plc. (AGN) Ex-Dividend Date Scheduled for August 16, 2018",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Novo Nordiskâ€™s Biopharmaceuticals Segment: An Update",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Biopharmaceuticals",
                        "Update"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "What's Next for Spark Therapeutics",
                "features": {
                    "keywords": [
                        "Spark",
                        "Therapeutics",
                        "Next"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "ViiV Healthcare: ATLAS Study Meets Primary Endpoint - Quick Facts",
                "features": {
                    "keywords": [
                        "ViiV",
                        "Healthcare",
                        "ATLAS",
                        "Study",
                        "Endpoint"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}